배너

2024.12.31 (화)

  • 맑음동두천 3.2℃
  • 맑음강릉 6.2℃
  • 맑음서울 2.4℃
  • 맑음인천 2.1℃
  • 맑음수원 3.8℃
  • 맑음청주 4.1℃
  • 맑음대전 5.5℃
  • 맑음대구 6.0℃
  • 맑음전주 4.5℃
  • 맑음울산 7.1℃
  • 맑음광주 5.6℃
  • 맑음부산 8.5℃
  • 맑음여수 7.3℃
  • 구름조금제주 9.6℃
  • 맑음천안 3.9℃
  • 맑음경주시 6.8℃
  • 맑음거제 8.3℃
기상청 제공

아이타임즈M

Kim Dong-yeon Il-Yang Pharmaceutical Seizes and Seeks Alleged Stock Price Manipulation

Kim Dong-yeon (CEO of Ilyang Pharmaceutical) announces false facts about the effectiveness of COVID-19 treatment...
Seizure and search for allegations of 'stock price manipulation’

 

Daily Union (Monthly, Korea News Newspaper) Ju-un Journalist | Ilyang Pharmaceutical was raided on the 5th on charges of violating the Capital Markets Act.

 

This is because suspicions arose that Ilyang Pharmaceutical manipulated Zucca by deceiving that its COVID-19 treatment was effective.

 

According to the Seoul Metropolitan Police Agency's Financial Crime Investigation Unit, Ilyang Pharmaceutical announced in March 2020 that its leukemia treatment, "Spect," is effective in treating COVID-19.

 

Ilyang Pharmaceutical found that the COVID-19 virus decreased by 70% compared to the control group within 48 hours after "Spect" was administered to COVID-19 patients.

 

As soon as the company announced in March 2020 that its COVID-19 treatment "Spect" was effective, the weekly price, which was around 20,000 won, soared to 106,500 won.

 

The Financial Crime Investigation Unit reportedly investigated some executives, including major shareholders of Ilyang Pharmaceutical, because they believed they enjoyed market profits by selling their holdings in time for the soaring price of Ilyang Pharmaceutical.

 




배너

SNS TV

더보기

가장 많이 본 뉴스